IRIDEX (IRIX) Competitors $1.64 -0.07 (-4.09%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends IRIX vs. TELA, GUTS, FONR, MGRM, ECOR, LNSR, EDAP, NSPR, VANI, and HYPRShould you be buying IRIDEX stock or one of its competitors? The main competitors of IRIDEX include TELA Bio (TELA), Fractyl Health (GUTS), FONAR (FONR), Monogram Orthopaedics (MGRM), electroCore (ECOR), LENSAR (LNSR), Edap Tms (EDAP), InspireMD (NSPR), Vivani Medical (VANI), and Hyperfine (HYPR). These companies are all part of the "medical equipment" industry. IRIDEX vs. TELA Bio Fractyl Health FONAR Monogram Orthopaedics electroCore LENSAR Edap Tms InspireMD Vivani Medical Hyperfine TELA Bio (NASDAQ:TELA) and IRIDEX (NASDAQ:IRIX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, community ranking, earnings, dividends, media sentiment, valuation, profitability and institutional ownership. Which has more risk & volatility, TELA or IRIX? TELA Bio has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500. Comparatively, IRIDEX has a beta of 0.81, meaning that its share price is 19% less volatile than the S&P 500. Does the MarketBeat Community prefer TELA or IRIX? IRIDEX received 213 more outperform votes than TELA Bio when rated by MarketBeat users. However, 74.68% of users gave TELA Bio an outperform vote while only 64.92% of users gave IRIDEX an outperform vote. CompanyUnderperformOutperformTELA BioOutperform Votes5974.68% Underperform Votes2025.32% IRIDEXOutperform Votes27264.92% Underperform Votes14735.08% Which has preferable valuation and earnings, TELA or IRIX? IRIDEX has lower revenue, but higher earnings than TELA Bio. IRIDEX is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTELA Bio$68.65M1.64-$46.66M-$1.69-1.69IRIDEX$48.43M0.56-$9.57M-$0.67-2.45 Does the media refer more to TELA or IRIX? In the previous week, IRIDEX had 3 more articles in the media than TELA Bio. MarketBeat recorded 3 mentions for IRIDEX and 0 mentions for TELA Bio. TELA Bio's average media sentiment score of 0.00 equaled IRIDEX'saverage media sentiment score. Company Overall Sentiment TELA Bio Neutral IRIDEX Neutral Do analysts rate TELA or IRIX? TELA Bio presently has a consensus target price of $9.25, indicating a potential upside of 224.56%. IRIDEX has a consensus target price of $2.00, indicating a potential upside of 21.95%. Given TELA Bio's stronger consensus rating and higher probable upside, research analysts plainly believe TELA Bio is more favorable than IRIDEX.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TELA Bio 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00IRIDEX 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do insiders and institutionals have more ownership in TELA or IRIX? 94.3% of TELA Bio shares are held by institutional investors. Comparatively, 20.1% of IRIDEX shares are held by institutional investors. 6.0% of TELA Bio shares are held by insiders. Comparatively, 7.3% of IRIDEX shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is TELA or IRIX more profitable? IRIDEX has a net margin of -22.79% compared to TELA Bio's net margin of -60.49%. IRIDEX's return on equity of -192.95% beat TELA Bio's return on equity.Company Net Margins Return on Equity Return on Assets TELA Bio-60.49% -556.18% -63.13% IRIDEX -22.79%-192.95%-33.97% SummaryTELA Bio beats IRIDEX on 9 of the 17 factors compared between the two stocks. Ad Brownstone ResearchMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. Get IRIDEX News Delivered to You Automatically Sign up to receive the latest news and ratings for IRIX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRIX vs. The Competition Export to ExcelMetricIRIDEXElectromedical equipment IndustryComputer SectorNASDAQ ExchangeMarket Cap$27.28M$3.01B$25.83B$9.08BDividend YieldN/A1.75%2.77%4.22%P/E Ratio-2.4516.64237.9417.18Price / Sales0.5650.153,330.10116.79Price / CashN/A39.9135.8537.86Price / Book2.783.728.094.78Net Income-$9.57M$89.83M$681.16M$225.60M7 Day Performance-4.65%-1.82%0.43%-1.23%1 Month Performance-4.65%0.28%6.99%3.36%1 Year Performance-37.28%4.10%23.04%16.59% IRIDEX Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRIXIRIDEX0.3499 of 5 stars$1.64-4.1%$2.00+22.0%-37.2%$27.28M$48.43M-2.45120Analyst ForecastNews CoverageTELATELA Bio2.9938 of 5 stars$2.85+2.9%$9.25+224.6%-49.8%$112.26M$58.45M-1.64120GUTSFractyl Health0.8828 of 5 stars$2.10+2.9%$22.00+947.6%N/A$101.01M$120,000.00-0.17102FONRFONAR1.0041 of 5 stars$15.38-1.0%N/A-25.8%$97.33M$102.01M11.09480MGRMMonogram Orthopaedics3.2328 of 5 stars$2.78+4.5%$4.00+43.9%-24.1%$95.39M$364,999.00-5.6628Gap DownECORelectroCore2.6011 of 5 stars$14.15+4.0%N/A+164.2%$92.75M$23.33M-7.4450Analyst ForecastAnalyst RevisionNews CoverageLNSRLENSAR0.569 of 5 stars$7.48-0.9%$8.00+7.0%+191.7%$86.88M$48.87M-5.17110News CoverageEDAPEdap Tms3.2791 of 5 stars$2.24+1.8%$19.00+748.2%-56.2%$83.11M$63.41M-3.38307NSPRInspireMD2.1967 of 5 stars$3.00+1.7%$4.75+58.3%+45.6%$78.25M$6.82M-3.9350Analyst ForecastGap UpVANIVivani Medical2.7875 of 5 stars$1.31flat$3.00+129.0%+34.6%$77.60MN/A-2.9120News CoverageHYPRHyperfine2.2901 of 5 stars$0.98-2.0%$1.60+63.3%-15.7%$71.49M$13.26M-1.75190 Related Companies and Tools Related Companies TELA Alternatives GUTS Alternatives FONR Alternatives MGRM Alternatives ECOR Alternatives LNSR Alternatives EDAP Alternatives NSPR Alternatives VANI Alternatives HYPR Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IRIX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IRIDEX Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share IRIDEX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
